THE MEASUREMENT OF BETA-PHENYLETHYLAMINE IN HUMAN PLASMA AND RAT-BRAIN

被引:12
作者
HUEBERT, ND
SCHWACH, V
RICHTER, G
ZREIKA, M
HINZE, C
HAEGELE, KD
机构
[1] Department of Pharmacokinetics, Marion Merrell Dow, 67080 Strasbourg Cédex, 16, rue d 'Ankara
关键词
D O I
10.1006/abio.1994.1375
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive and specific analytical method has been developed for the measurement of beta-phenylethylamine (PEA) in human plasma and rat brain extracts. The method involves solvent extraction of PEA with cycle-hexane in the presence of amphetamine or phenylpropylamine (PPA) as internal standards. Automated precolumn derivatization with o-phthalaldehyde and 2-mercaptoethanol followed by reverse-phase HPLC separated PEA and PPA from endogenous interferences. Detection and quantification were carried out by amperometric detection at +0.75 V relative to a Ag/AgCl reference electrode or by coulometric detection with analytical cell potentials set at +0.29 and +0.50 V. The limit of detection for PEA was 10 pg and the limit of quantification in plasma was 60 pg/ml. The within-day and day-to-day coefficients of variation were 16.1% (n = 3) and 40.6% (n = 8), respectively, at a plasma concentration of 154 pg/ml and 15.2% (n = 5) and 28% (n = 10) at a brain extract concentration of 110 pg/ml. Basal endogenous plasma PEA concentrations of 335 +/- 255 pg/ml (n = 12, range 127-1002 pg/ml) were found for normal volunteers and single, daily doses of 24 mg but not 12 mg of the MAO-B inhibitor, mofegiline, were shown to increase plasma PEA significantly. Basal whole brain and striatal concentrations were 0.584 +/- 0.243 ng/g wet wt (n = 3) and 2.89 +/- 1.03 ng/g wet wt (n = 4), respectively. Statistically significant increases (5.7-fold) in rat whole brain PEA concentrations were seen 3 and 6 h following the administration of a single dose of 0.3 mg/kg mofegiline to rats. (C) 1994 Academic Press,Inc.
引用
收藏
页码:42 / 47
页数:6
相关论文
共 21 条
[1]  
ALVAREZCOQUE MCG, 1989, ANAL BIOCHEM, V178, P1
[2]   PHENYLETHYLAMINERGIC MODULATION OF CATECHOLAMINERGIC NEUROTRANSMISSION [J].
BOULTON, AA .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1991, 15 (02) :139-156
[3]   BIOGENIC-AMINES AND THEIR METABOLITES IN BODY-FLUIDS OF NORMAL, PSYCHIATRIC AND NEUROLOGICAL SUBJECTS [J].
DAVIS, BA .
JOURNAL OF CHROMATOGRAPHY, 1989, 466 :89-218
[4]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF BIOGENIC-AMINES IN BIOLOGICAL-MATERIALS AS ORTHO-PHTHALALDEHYDE DERIVATIVES [J].
DAVIS, TP ;
GEHRKE, CW ;
GEHRKE, CW ;
CUNNINGHAM, TD ;
KUO, KC ;
GERHARDT, KO ;
JOHNSON, HD ;
WILLIAMS, CH .
JOURNAL OF CHROMATOGRAPHY, 1979, 162 (03) :293-310
[5]   ENANTIOSPECIFIC DRUG ANALYSIS VIA THE ORTHO-PHTHALALDEHYDE HOMOCHIRAL THIOL DERIVATIZATION METHOD [J].
DESAI, DM ;
GAL, J .
JOURNAL OF CHROMATOGRAPHY, 1993, 629 (02) :215-228
[6]   POSTCOLUMN DETECTION BY ONLINE PHOTOLYSIS ELECTROCHEMISTRY IN LIQUID-CHROMATOGRAPHY - APPLICATION TO THE DETERMINATION OF PHENYLALANINE IN HUMAN URINE [J].
DOU, L ;
KRULL, IS .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (06) :493-498
[7]   DETERMINATION OF AROMATIC AND SULFUR-CONTAINING AMINO-ACIDS, PEPTIDES, AND PROTEINS USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH PHOTOLYTIC ELECTROCHEMICAL DETECTION [J].
DOU, L ;
KRULL, IS .
ANALYTICAL CHEMISTRY, 1990, 62 (23) :2599-2606
[8]  
DULERY BD, 1993, ARZNEIMITTEL-FORSCH, V43-1, P297
[9]  
DURDEN DA, 1980, J NEUROCHEM, V34, P1725
[10]   PROBLEMS IN THE ANALYSIS OF LOW-LEVELS OF AMINO-ACIDS IN PHYSIOLOGICAL FLUIDS AND TISSUES USING ORTHO-PHTHALALDEHYDE DERIVATIZATION AND REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].
HOSKINS, JA ;
HOLLIDAY, SB ;
DAVIES, FF .
JOURNAL OF CHROMATOGRAPHY, 1986, 375 (01) :129-133